These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7398183)

  • 1. Plasma timolol levels and systolic time intervals.
    Singh BN; Williams FM; Whitlock RM; Collett J; Chew C
    Clin Pharmacol Ther; 1980 Aug; 28(2):159-66. PubMed ID: 7398183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1975 Sep; 18(3):278-86. PubMed ID: 1100298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1976 Feb; 19(2):148-52. PubMed ID: 4254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.
    Ferguson RK; Vlasses PH; Koplin JR; Holmes GI; Huber P; Demetriades J; Abrams WB
    Br J Clin Pharmacol; 1982 Nov; 14(5):719-25. PubMed ID: 6128021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.
    Ishizaki T; Tawara K
    Eur J Clin Pharmacol; 1978 Nov; 14(1):7-14. PubMed ID: 32043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propranolol and timolol on left ventricular volumes during exercise in patients with coronary artery disease.
    Kalischer AL; Johnson LL; Johnson YE; Stone J; Feder JL; Escala E; Cannon PJ
    J Am Coll Cardiol; 1984 Jan; 3(1):210-8. PubMed ID: 6690552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of intravenous timolol in coronary artery disease.
    Chew CY; Collett J; Shah PK; Singh BN
    Clin Pharmacol Ther; 1979 Sep; 26(3):330-8. PubMed ID: 466927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade.
    Wilson TW; Firor WB; Johnson GE; Holmes GI; Tsianco MC; Huber PB; Davies RO
    Clin Pharmacol Ther; 1982 Dec; 32(6):676-85. PubMed ID: 7140133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals.
    Ishizaki T; Tawara K; Oyama Y; Nakaya H
    J Clin Pharmacol; 1978; 18(11-12):511-8. PubMed ID: 721948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the beta-adrenergic blocking agents propranolol and timolol on canine cardiac refractory periods.
    Jaillon P; Weissenburger J; Heckle J; Cheymol G
    Eur J Pharmacol; 1979 Oct; 58(3):265-71. PubMed ID: 510358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of prolonged administration of propranolol and timolol on the growth and the heart of growing rabbits.
    Evemy KL; Cummins P; Littler WA
    Clin Sci (Lond); 1981 Jan; 60(1):33-40. PubMed ID: 7237922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
    González-Gómez A; García-Barreto D; Gamio Capestany F; Hernández-Cañero A; Fong Chi S
    Cor Vasa; 1982; 24(6):422-8. PubMed ID: 6764167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oxprenolol and propranolol on systolic time intervals.
    van Herick R; Aronow WS
    Clin Pharmacol Ther; 1978 Dec; 24(6):678-82. PubMed ID: 361333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol dosage, plasma concentration, and beta blockade.
    Mullane JF; Kaufman J; Dvornik D; Coelho J
    Clin Pharmacol Ther; 1982 Dec; 32(6):692-700. PubMed ID: 7140135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal timolol: beta blockade and plasma concentrations after application for 48 hours and 7 days.
    McCrea JB; Vlasses PH; Franz TJ; Zeoli L
    Pharmacotherapy; 1990; 10(4):289-93. PubMed ID: 2388875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of timolol eye drops in subjects receiving systemic propranolol therapy.
    Blondeau P; Côté M; Tétrault L
    Can J Ophthalmol; 1983 Feb; 18(1):18-21. PubMed ID: 6340806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of action of beta blockers.
    Johansson SR; McCall M; Wilhelmsson C; Vedin JA
    Clin Pharmacol Ther; 1980 May; 27(5):593-601. PubMed ID: 6102896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of timolol on platelet aggregation in coronary heart disease.
    Thaulow E; Kjekshus J; Erikssen J
    Acta Med Scand Suppl; 1981; 651():101-9. PubMed ID: 7034470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.